ArticleFrontiers in oncology2022

Safety and efficacy of radiotherapy combined with lenvatinib plus PD-1 inhibitors as neo-adjuvant therapy in hepatocellular carcinoma with portal vein thrombus: protocol of an open-label, single-arm, prospective, multi-center phase I trial.

Guangxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.